Related Experiment Video
Updated: Aug 11, 2026

Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage
Published on: August 4, 2021
[Recurrent miscarriage and thrombophilia]
1Academisch Medisch Centrum/Universiteit van Amsterdam, Postbus 22.660, 1100 DD Amsterdam. s.middeldorp@amc.uva.nl
Abstract:
In more than half of the couples with recurrent miscarriage, no underlying cause can be found. Both acquired and hereditary risk factors for venous thrombosis, i.e. thrombophilia, constitute an aetiologic factor in a minority of patients with recurrent miscarriage. In women with a diagnosis of antiphospholipid antibody syndrome, treatment with low-dose acetylsalicylic acid and low-molecular-weight heparin has been shown by a valid randomised controlled trial to improve the results of a subsequent pregnancy. However, it is unknown whether anticoagulant treatment of women with recurrent miscarriage and hereditary risk factors for thrombophilia improves the outcome of a subsequent pregnancy.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Hemorrhagic Stroke l: Introduction
